Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tyrosine kinase fak'

Search results for: 'research area tyrosine kinase fak'

Items 191-200 of 200

Page
per page
  1. XMD8-92
    A3943 XMD8-92
    Target: ERK
    Summary: BMK1/ERK5 inhibitor
      ≥23.75 mg/mL
  2. GSK690693
    A5072 GSK690693
    Target: Akt|PKC|PKG|PKA|Prk
    Summary: Pan-AKT inhibitor,ATP-competitive and potent
      ≥21.25 mg/mL
  3. OSU-03012 (AR-12)
    A2846 OSU-03012 (AR-12)
     1 Citation
    Target: PDK-1
    Summary: Potent PDK1 inhibitor
      ≥23 mg/mL
  4. LY 294002
    A8250 LY 294002
     16 Citation
    Target: PI3K
    Summary: Potent PI3K inhibitor
  5. BS-181
    A3266 BS-181
    Target: Cyclin-Dependent Kinases
    Summary: CDK7 inhibitor,highly selective
      Soluble in DMSO
  6. Plumbagin
    A4456 Plumbagin
    Summary: Anticancer agent
  7. Dabrafenib Mesylate (GSK-2118436)
    A3347 Dabrafenib Mesylate (GSK-2118436)
    Target: Raf
    Summary: Inhibitor of BRAF(V600) mutants
      ≥30.75 mg/mL
  8. Flavopiridol
    A3417 Flavopiridol
    Target: Cyclin-Dependent Kinases
    Summary: Pan-cdk inhibitor
      insoluble in H2O; ≥40.2 mg/mL
  9. SB202190 (FHPI)
    A1632 SB202190 (FHPI)
     5 Citation
    Target: p38
    Summary: P38 MAPK inhibitor
  10. GDC-0941
    A8210 GDC-0941
     10 Citation
    Target: PI3K
    Summary: PI3K inhibitor,potent and selective
      ≥25.7 mg/mL

Items 191-200 of 200

Page
per page
Shop By
Now Shopping by
  1. Related Disease Cancer Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 199item
Specificity
  1. Selective 155item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 18item
  2. Irreversible 6item
Target
  1. Cyclin-Dependent Kinases 22item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 4item
  4. PI3K 11item
  5. Raf 9item
  6. Aurora Kinases 16item
  7. CSF-1R 4item
  8. mTOR 5item
  9. FLT3 7item
  10. GSK-3 4item
  11. PLK 5item
  12. Chk 4item
  13. Eph Receptors 3item
  14. VEGFR 27item
  15. PDGFR 17item
  16. c-Kit 9item
  17. RET 4item
  18. Bromodomain-containing proteins(BRDs) 1 item
  19. p38 3item
  20. JNK 1 item
  21. SGK 2item
  22. Bcr-Abl 6item
  23. MEK 2item
  24. FGFR 9item
  25. Pim 3item
  26. Ribosomal s6 kinases (RSK) 1 item
  27. MET 5item
  28. Src 8item
  29. Trk Receptors 1 item
  30. STAT 2item
  31. EGFR 13item
  32. PAK 3item
  33. FAK 7item
  34. BMP and Other Activin Receptors 1 item
  35. JAK 8item
  36. Syk 3item
  37. DNA-PK 4item
  38. ErbB 4item
  39. ERK 2item
  40. c-MET 5item
  41. PKC 8item
  42. Ubiquitin-specific proteases 1 item
  43. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  44. Lyn 1 item
  45. HER2 1 item
  46. Pyk2 3item
  47. Insulin and Insulin-like Receptors 2item
  48. ALK 6item
  49. ROS1 1 item
  50. Sphingosine kinases (SphKs) 1 item
  51. PKG 2item
  52. PKA 4item
  53. Myosin light chain kinases (MLCKs) 1 item
  54. MELK 1 item
  55. Insulin-like growth factors (IGFs) 1 item
  56. MK2 1 item
  57. Tie-2 1 item
  58. RSK 1 item
  59. ATM/ATR 3item
  60. CK1 1 item
  61. Farnesyl Diphosphate Synthases 1 item
  62. CK2 1 item
  63. HIPK2 1 item
  64. HIPK3 1 item
  65. P110 1 item
  66. Hck 1 item
  67. MNK 1 item
  68. Insulin Receptors 1 item
  69. IRG-1R 1 item
  70. eEF-2 1 item
  71. Cdc7 1 item
  72. ZAP-70 1 item
  73. c-RET 2item
  74. p70 rsk 1 item
  75. VEGFR3/FLT4 1 item
  76. NTRK1/TRKA 1 item
  77. CSF-1R/c-Fms 1 item
  78. TAM kinase 1 item
  79. KDR 1 item
  80. AXL 1 item
  81. insulin 1 item
  82. ErbB-2 1 item
  83. PDK-1 1 item
  84. Prk 1 item
  85. Flk1 2item
  86. tropomyosin receptor kinase 1 item
  87. SK 1 item
  88. PPK 1 item
  89. c-Syk 1 item
  90. CDK1/CyclinB 1 item
  91. PIM1 kinase 1 item
  92. phospholipase A2 1 item
Reported Experiments
  1. Animal Experiments 187item
  2. Cell Experiments 124item